Hanmi releases dexibuprofen ER tablets

Published: 2009-03-19 06:58:00

Updated: 2009-03-19 06:58:00

Hanmi Pharm said it has newly launched an extended release form of dexibuprofen 300 mg tablets for relief of sign and symptoms of osteoarthritis, rheumatoidal disorders such as osseous rheumatism, ankylosing spondilitis, juvenile arthritis, muscular rheumatism, degenerative joint diseases.

Twice-daily dexibuprofen is an over-the-counter medicine and considered as the pharmacologically active...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.